US drug regulator issues warning on certain multiple sclerosis drugs
The US drug regulator has issued its most prominent warning on the use of certain drugs to treat multiple sclerosis, saying it may.
Drugs
Health
Pharma
Henlius, Organon trial drug meets goal of an absence of breast cancer
Shanghai Henlius Biotech, Inc., and US-based Organon & Co. announced their end-stage trial for investigational breast cancer had met its main goal of.
Drugs
Health
Pharma
US drug regulator clears Amgen’s biosimilar to treat rare blood disorder
The US drug regulator has approved Amen’s biosimilar, Bkemv, to treat rare blood disorders, according to a statement from the Food and Drug.
Drugs
Pharma
Biocon signs out-licencing pact with Yoshindo
HQ Team October 17, 2022: Biocon Biologics, a subsidiary of India’s Biocon, has inked an out-licencing pact with Japan’s Yoshindo Inc for selling.